Antifungal Chemical Compounds Identified Using a C. elegans Pathogenicity Assay

• Julia Breger,

  Affiliation Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯
• Beth Burgwyn Fuchs,

  Affiliation Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯
• George Aperis,

  Affiliation Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯
• Terence I Moy,

  Affiliation Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Frederick M Ausubel,

  Affiliations Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America , Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Eleftherios Mylonakis

  *To whom correspondence should be addressed. E-mail: emylonakis@partners.org

  Affiliation Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯